Product Images Perseris

Q PERSERIS is an extended-release injectable suspension containing risperidone, used for abdominal subcutaneous injection only. The kit includes two patches and one pouch containing a pre-filled syringe with risperidone powder designed to deliver 50mg of risperidone after mixing and a liquid syringe containing inactive ingredients. The product must be stored at 2°C to 8°C and may be stored unopened at room temperature for up to 7 days. Mixing is necessary prior to administration and the instructions should be read carefully before use.*

This is a medication called PERSERIS, which contains the active ingredient risperidone. It is an extended-release injectable suspension meant for subcutaneous injection in the abdomen. The medication is delivered through a prefilled syringe containing both powder and liquid medication. The powder must be mixed with the liquid prior to use. This medication is meant for once-monthly use and should be administered only by a healthcare professional. Additional prescribing information is included with the medication. *

This text is describing the delivery system and contents of a sterile single-dose liquid syringe for PERSERIS™ 90 mg injection. The delivery system is pre-filled with inactive ingredients for abdominal subcutaneous injection only. The pouch must be allowed to come to room temperature for at least 16 minutes before mixing with the powder syringe. The full prescribing information should be consulted before use. The product is manufactured for Indivior Inc. in North Chesterfield, VA, and was developed by AMRI Global in Burlington, MA.*

The text is a product label for PERSERIS™, a medication that contains risperidone and is intended for subcutaneous powder injection only. The label includes the lot number, expiration date, and manufacturer information. There is also a section mentioned with "Unvarnished area for wrap", however, the context for this section is not available.*

This is a prescription-only sterile liquid syringe with the NDC code of 12496-0589-5. Manufactured by AMRI Global, it is recommended to be used only for abdominal subcutaneous injection. The package includes a delivery system and an unvarnished area for wrap. It also includes a lot number and an expiration date.*

PERSERIS (risperidone) is a once-monthly extended-release injectable suspension used for abdominal subcutaneous injection. The kit includes two pouches with pre-filled syringes and one syringe delivery system. The user is advised to read the complete instructions before use, as it is necessary to mix the ingredients before administration. The product should be stored at room temperature and may be stored in the original unopened packaging for up to seven days. PERSERIS should be discarded if not used within 28 days after removal from the refrigerator.*

The text describes a medication called "PERSERIS" (risperidone) for extended-release injectable suspension, with a strength of 120 mg. The medication is meant to be injected once a month into the abdomen, and the contents of the powder syringe must be mixed with liquid before use. The text recommends reading the full prescribing information and indicates that the medication is for prescription use only. The manufacturer is Indivior Inc., and the medication is produced in North Chesterfield, VA.*

This is a prescription-only medication called PERSERIS, which contains 450mg of risperidone. It is intended for subcutaneous injection into the abdomen only and comes in a sterile powdered form in a syringe. The product is manufactured by Patheon Mfr. The label shows a lot number and expiration date. There is a blank area on the label for wrapping the product.*

This text provides information about the delivery system for PERSERIS™ 120 mg medication. The product is indicated for liquid subcutaneous injection only and is sterile. Details such as lot number, expiration date, and manufacturer are also included. The text ends with a reference to an "unvarnished area for wrap," which is unclear without further context.*

This is a description for an extended-release injectable suspension called PERSERIS. The package has instructions for use, storage, and handling. The drug is risperidone and is to be used for abdominal subcutaneous injection only. Following the instructions is necessary before use. The package has two pouches: one of them contains a powder syringe, and the other has a protective cover for the syringe. The drug has to be stored between 20°C and 25°C. The shelf life of the drug after removing it from refrigeration is seven days.*

The given text describes a product called "O PERSERIS," containing risperidone for abdominal subcutaneous injection only. It is advised to read complete instructions before use. The pouch contents contain a powder syringe designed to deliver 0mg risperidone after mixing with the delivery system. It is manufactured for "Indiviornc" in North Chesterfield, VA, by Patheon M. Services in Greenville, NC. The product sample is not for sale, and the information is as of July 2018.*

This is a package insert for a medical delivery system meant for abdominal subcutaneous injection only. The product includes a liquid syringe pre-filled with delivery system designed to deliver an active ingredient. It also contains a powder syringe that must be mixed with the contents of the liquid syringe prior to use. The product should only be used as directed after reading the complete instructions and full prescribing information. The product is sterile and single-dose only. The manufacturing company is located in North Chesterfield, VA, and the product was manufactured in July 2018.*

This text indicates that a medication or injection is intended for subcutaneous use only in the abdominal area.*

PERSERIS is a monthly extended-release injectable suspension of risperidone available in 120mg strength. It is administered via abdominal subcutaneous injection and should be readied as per complete instructions provided. The kit contains two pouches, one containing a powder syringe, an instruction manual, and 500mg of diluent. The PERSERIS kit should not be used without coming to room temperature for at least 15 minutes. Unused PERSERIS may be stored unopened in the original package at room temperature. PERSERIS should be stored between 2°C to 25°C and discarded after a certain number of days once opened or after a specified date.*

This is a description of PERSERIS, an extended-release injectable suspension for abdominal subcutaneous injection. The POUCH CONTENTS include a Powder Syringe pre-filled with risperidone powder designed to deliver 120 mg after mixing with the delivery system, and it must be mixed with the liquid provided in the other pre-filled Liquid Syringe prior to use. The product is manufactured for Indivior Inc. in North Chesterfield, VA. Please see accompanying Full Prescribing Information before use.*

This is a description of the delivery system for PERSERIS 120 mg, used for abdominal subcutaneous injection. The pouch contains a liquid syringe pre-filled with delivery system designed to deliver 0.8 mL containing inactive ingredients including poly DL lactide co-glycolide with an 80:20 molar ratio of lactide to glycolide (304 mg) and N-methyl-pyrrolidone. This must be mixed with the powder provided in the other pre-filled powder syringe prior to use. It is manufactured for Indivior Inc. by AMRI Global. Detailed instructions are included, and it should only be used by prescription. It is not for sale as it's a sample.*

The text is a description of a medication called PERSERIS (risperidone) which is available only via a prescription with the National Drug Code (NDC) 12496-0120-7. It is in sterile subcutaneous powder injection form with a dosage of 120mg, and it is manufactured by Patheon Mfr. It is indicated for abdominal use only and is available as a sample with a syringe.*

This is a delivery system sample for the medication PERSERIS® 120 mg. It is intended for subcutaneous injection into the abdominal area only and is sterile and for prescription use only (Rx only). The manufacturer appears to be MRI Global.*